Stocktoria

MANNATECH INC MTEX

Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 1999-02-16

MANNATECH INC statistics & valuation

P / S0.1×
Net margin-14.1%
FCF margin-4.0%
Net cash$3.4M
Net debt / EBITDA-5.2×
Enterprise value USD$6.3M
EV / EBITDA9.5×
Earnings yield EBIT/EV-6.7%
Return on capital-3.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-0.30% -1.00% -2.20% 2.10% 4.10% 6.20% -3.30% -1.70% 2.10% -14.10% 2016201720182019202020212022202320242025
Gross margin (%)
79.70% 79.80% 80.10% 80.00% 76.50% 78.60% 75.90% 78.00% 77.60% 74.90% 2016201720182019202020212022202320242025
Operating margin (%)
0.40% 1.40% -0.10% 4.10% 3.00% 5.70% -0.30% -0.70% 1.20% -0.40% 2016201720182019202020212022202320242025
Return on equity (%)
-1.50% -4.40% -15.30% 12.10% 24.10% 40.30% -31.70% -21.40% 28.90% 2016201720182019202020212022202320242025
Shares outstanding
2.7M 2.7M 2.5M 2.4M 2.3M 2.1M 1.9M 1.9M 1.9M 1.9M 2016201720182019202020212022202320242025
Net debt ($)
-$3.4M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-0.80% -2.30% -6.20% 5.20% 9.60% 16.50% -9.10% -5.40% 6.90% -50.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-1.30% 5.10% -1.50% 2.30% 3.40% 6.30% -2.70% -2.40% 1.70% -4.00% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.22 -$0.66 -$1.53 $1.35 $2.77 $4.71 -$2.35 -$1.20 $1.32 -$8.00 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

MANNATECH INC trades at about 3.8× earnings — below its 10-year norm (10-year range 6.7×–13×, median 8.2×).

3.8× 13×

Shaded band = 10-year range (6.7×–13×); dot = today's 3.8×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin74.9%77.6%78.0%75.9%78.6%76.5%80.0%80.1%79.8%79.7%
Operating margin-0.4%1.2%-0.7%-0.3%5.7%3.0%4.1%-0.1%1.4%0.4%
Net margin-14.1%2.1%-1.7%-3.3%6.2%4.1%2.1%-2.2%-1.0%-0.3%
FCF margin-4.0%1.7%-2.4%-2.7%6.3%3.4%2.3%-1.5%5.1%-1.3%
Return on assets-50.7%6.9%-5.4%-9.1%16.5%9.6%5.2%-6.2%-2.3%-0.8%
Return on equity291.3%28.9%-21.4%-31.7%40.3%24.1%12.1%-15.3%-4.4%-1.5%
Debt / equity-0.53×
Current ratio1.101.251.071.171.421.331.421.261.681.69

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.